UNICA IRIS Institutional Research Information System

SIMOLA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 174.702
NA - Nord America 10.989
AS - Asia 3.907
Continente sconosciuto - Info sul continente non disponibili 747
SA - Sud America 633
AF - Africa 104
OC - Oceania 10
Totale 191.092
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 172.664
US - Stati Uniti d'America 10.770
SG - Singapore 1.496
CN - Cina 1.403
BR - Brasile 504
UA - Ucraina 487
SE - Svezia 461
VN - Vietnam 374
DE - Germania 245
FI - Finlandia 206
GB - Regno Unito 204
FR - Francia 174
HK - Hong Kong 152
CA - Canada 102
IN - India 91
KR - Corea 57
BD - Bangladesh 56
PL - Polonia 51
AR - Argentina 44
MX - Messico 42
NL - Olanda 38
JP - Giappone 36
IQ - Iraq 32
ES - Italia 29
RU - Federazione Russa 29
ZA - Sudafrica 26
ID - Indonesia 24
PK - Pakistan 23
TR - Turchia 22
CO - Colombia 18
JM - Giamaica 18
MA - Marocco 18
BE - Belgio 17
EC - Ecuador 17
EG - Egitto 16
UZ - Uzbekistan 16
VE - Venezuela 16
AT - Austria 14
CH - Svizzera 14
CL - Cile 14
IL - Israele 14
SA - Arabia Saudita 14
PH - Filippine 13
IE - Irlanda 12
CZ - Repubblica Ceca 11
NI - Nicaragua 11
CR - Costa Rica 10
PE - Perù 10
MY - Malesia 9
AU - Australia 8
EU - Europa 8
JO - Giordania 8
KE - Kenya 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
LT - Lituania 7
RO - Romania 7
SV - El Salvador 7
TN - Tunisia 7
KZ - Kazakistan 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BB - Barbados 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
OM - Oman 5
TH - Thailandia 5
ET - Etiopia 4
PA - Panama 4
PT - Portogallo 4
UY - Uruguay 4
BG - Bulgaria 3
GT - Guatemala 3
NO - Norvegia 3
NP - Nepal 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SN - Senegal 3
TJ - Tagikistan 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
CM - Camerun 1
Totale 190.332
Salva come PNG Salva come JPEG
Città #
Cagliari 168.187
Uta 3.886
Ashburn 1.138
Fairfield 1.013
Singapore 734
Woodbridge 732
Chandler 594
San Jose 558
Dallas 540
Houston 441
Ann Arbor 396
Seattle 373
Wilmington 358
Cambridge 354
Boardman 325
Beijing 314
New York 290
Nyköping 289
Jacksonville 248
Council Bluffs 220
Dearborn 193
Los Angeles 163
Santa Clara 159
Hong Kong 132
Nanjing 113
Helsinki 112
The Dalles 107
Shanghai 106
Boston 98
Lauterbourg 98
Ho Chi Minh City 97
Hangzhou 93
Dong Ket 68
Hefei 59
Hanoi 57
Buffalo 56
San Diego 52
Seoul 52
Milan 46
Munich 44
Guangzhou 42
Chicago 39
São Paulo 39
Toronto 39
Brooklyn 37
Shenyang 35
Atlanta 34
London 33
Rome 33
Frankfurt am Main 32
Orem 30
Redondo Beach 29
Tokyo 29
Phoenix 28
Columbus 27
Norwalk 27
San Francisco 27
Tianjin 26
Nanchang 25
Redwood City 25
Falls Church 23
Montreal 23
Denver 22
Hebei 22
Washington 22
Warsaw 21
Mexico City 20
Sassari 20
Da Nang 19
Changsha 18
Chennai 18
Sestu 18
Cracow 17
Haiphong 16
Manchester 16
Mountain View 16
Verona 15
Amsterdam 14
Brussels 14
Jinan 14
Tashkent 14
Jiaxing 13
Ningbo 13
Zhengzhou 13
Brasília 12
Curitiba 12
Dhaka 12
Miami 12
Orange 12
Padova 12
Wuhan 12
Alexandria 11
Johannesburg 11
Lappeenranta 11
Philadelphia 11
Charlotte 10
Managua 10
New Delhi 10
North Bergen 10
Nuremberg 10
Totale 184.130
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.310
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.670
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.565
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 3.549
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.396
Role of Adenosine in the basal Ganglia 3.379
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.192
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 3.153
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 3.052
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 3.046
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 3.037
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.955
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2.864
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation 2.852
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.804
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2.746
Methylxanthines and drug dependence: interactions and toxicity 2.739
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.699
Amphetamine usage, misuse, and addiction processes: an overview 2.662
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.645
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2.564
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 2.550
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.547
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 2.546
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 2.541
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.534
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations 2.457
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation 2.427
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.411
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.370
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 2.299
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 2.255
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.159
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 2.142
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.126
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state 2.126
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug 2.011
Preface [ to The Adenosinergic System. A Non-Dopaminergic Target in Parkinson’s Disease] 2.001
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1.982
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease 1.949
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1.896
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease 1.870
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease 1.849
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 1.840
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.830
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions 1.817
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.795
Repertoire and Biological Function of Ultrasonic Vocalizations in Adolescent and Adult Rats 1.735
null 1.722
Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi 1.699
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.677
null 1.651
Effects of Psychostimulants on Rat Emotional States and Emission of Ultrasonic Vocalizations 1.554
The sweet road to Parkinson's disease 1.542
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences 1.508
Adenosine A2A receptors: localization and function 1.491
Ultrasonic vocalizations in rats: a tool for the investigation of psychoactive drugs and neuropsychiatric conditions 1.485
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.481
Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states 1.425
Adenosine signaling in the basal ganglia 1.320
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.309
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.304
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease 1.274
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.226
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.216
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice 1.213
The 6-hydroxydopamine model of Parkinson's disease 1.202
null 1.194
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 1.163
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.150
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.150
A2A receptor antagonism and dyskinesia in Parkinson’s Disease 1.123
null 1.108
Caffeine Consumption and Changes in the Function of Dopaminergic Transmission: Evidence of a Hyperdopaminergic State in Rats Subchronically Treated with Caffeine 1.101
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.061
Perinatal asphyxia: CNS development and deficits with delayed onset 1.060
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.055
Anxyiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity 1.052
Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse 1.044
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences 1.024
null 1.012
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 987
Lack of drug- and cue-stimulated emissions of ultrasonic vocalizations in C57BL/6 J mice repeatedly treated with amphetamine 981
null 967
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins 952
Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction 935
What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years? 903
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory 894
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice 891
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward. 822
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings 797
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats 795
Caffeine 791
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 773
Can dietary substances protect against Parkinson's disease? The case of caffeine 750
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects 704
null 685
Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects 633
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis 609
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows 605
Totale 181.014
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.945 0 0 0 770 740 687 720 604 759 1.075 1.110 1.480
2022/202317.432 1.649 2.449 1.978 1.467 1.488 1.707 837 1.260 1.134 1.264 1.513 686
2023/202415.716 713 740 548 865 1.643 2.554 2.484 1.094 709 1.113 1.602 1.651
2024/202523.526 4.557 4.795 3.957 3.215 1.708 1.964 2.040 165 355 273 309 188
2025/20268.812 776 356 893 658 729 539 1.830 543 499 1.002 492 495
2026/20272.642 298 399 1.002 943 0 0 0 0 0 0 0 0
Totale 191.092